Lascaux Pharmaceuticals Limited
03230603
Some Concerns
- Negative net worth (-10)
- 3 outstanding charges (-6)
Details
Compliance
Last accounts
30/09/2025
micro entity
Next accounts due
30/06/2027
Confirmation statement
Last: 29/07/2025
Due 12/08/2026
Industry
Officers
director · Since 29/07/1996
PROFESSOR
AMERICAN · ENGLAND · Age 76
Also on 6 other boards
Persons with Significant Control
Professor Thomas William Rademacher
American · England · Age 76
2a Dunmore Court, Lascaux Pharma, Abingdon, OX13 6BH
Notified 06/04/2016
Charges3 outstanding
JOHN RICHARD ARNOLD BINNING AND RUTH ELIZABETH BINNING
JOHN RICHARD ARNOLD BINNING AND RUTH ELIZABETH BINNING
JOHN RICHARED ARNOLD BINNING & RUTH ELIZABETH BINNING
CompanyRankvs 29827+ SIC 86900 peers43
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Outstanding charges: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Key FinancialsYear ending 30/09/2025
Net Worth
-£46k
Balance sheet strength
Cash
—
Cash in the bank
Net Current Assets
£6k
Working capital
Current Assets
£7k
Current Liabilities
£2k
Fixed Assets
£1k
Balance Sheet
EstimatesDerived
| Year | Current Ratio | Implied Profit |
|---|---|---|
| 2025 | 4.80 | -£2k |
| 2024 | 6.88 | -£3k |
| 2023 | 11.16 | +£9k |
| 2022 | 0.06 | -£46k |
| 2021 | 7.01 | — |
| 2020 | 19.40 | — |
| 2019 | 0.20 | -£465 |
| 2018 | 0.21 | — |
Derived from filed accounts. Not audited figures.